Purdue Pharma Offers Plan to End Sackler Control and Mounting Lawsuits
The OxyContin maker filed its long-awaited restructuring plan in bankruptcy court. Revenue from the new company would go exclusively to abating the opioid crisis. (Source: NYT Health)
Source: NYT Health - March 16, 2021 Category: Consumer Health News Authors: Jan Hoffman and Mary Williams Walsh Tags: Suits and Litigation (Civil) Bankruptcies Opioids and Opiates OxyContin (Drug) Purdue Pharma Sackler Family Source Type: news

Hudson Woman Sentenced to 15 Months for Tampering with Consumer Products and Unlawfully Obtaining Controlled Substances
FDA OCI, Kristina Coleman, Hudson NH, sentence, tampering, opioid, pharmacy technician, Nashua, oxycodone, baclofen, suboxone, muscle relaxant, replacement, controlled substance, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - March 2, 2021 Category: Medical Law Authors: DOJ Source Type: news

Study shows opioid use among US patients with knee osteoarthritis costs 14 billion dollars in societal costs
(Wiley) Although guidelines do not recommend use of opioids to manage pain for individuals with knee osteoarthritis, a recent study published early online in Arthritis Care& Research, an official journal of the American College of Rheumatology and the Association of Rheumatology Professionals, estimates that 858,000 Americans use opioids such as tramadol and oxycodone for their knee pain, equating to $14 billion in lifetime opioid-related societal costs, or nearly $0.5 billion annually. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 25, 2021 Category: International Medicine & Public Health Source Type: news

Head of McKinsey, Kevin Sneader, Voted Out as Firm Faces Reckoning on Opioid Crisis
Partners decided not to keep Kevin Sneader in the top job. Weeks earlier, McKinsey had reached a historic settlement agreement in the U.S. over its advice to drugmakers. (Source: NYT Health)
Source: NYT Health - February 24, 2021 Category: Consumer Health News Authors: Michael Forsythe Tags: McKinsey & Co Sneader, Kevin David Appointments and Executive Changes Opioids and Opiates OxyContin (Drug) Purdue Pharma Source Type: news

Dark Web Trafficker Pleads Guilty to Distributing Opioids
FDA OCI, Daren Reid, Ft. Lauderdale FL, guilty, distribute, opioids, dark web, Oxyflight, Imperial Royalty, oxycodone, morphine, Silk Road, Wall Street, Apollon, drug trafficking, prescription drugs, Bitcoin, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - February 12, 2021 Category: Medical Law Authors: DOJ Source Type: news

Mexico ’s poor have little luck obtaining opioids intended for palliative care
If you ’re poor and terminally ill in southern Mexico, there’s far less chance you’ll get the painkillers you need for palliative care than your cousins in more prosperous regions, particularly those pharmacy-rich areas along Mexico–U.S. border, say UCLA researchers and colleagues who studied opioi d dispensing levels across the country.What ’s more, the researchers’ paper in the journalThe Lancet Public Health suggests it ’s likely that some of the opioids intended for Mexican citizens are ending up in American pockets.Despite a Mexican government initiative launched in 2015 to improve access to prescription...
Source: UCLA Newsroom: Health Sciences - February 11, 2021 Category: Universities & Medical Training Source Type: news

Abuse-deterrent extended-release oxycodone and risk of opioid-related harm - Paljarvi T, Strang J, Quinn PD, Luciano S, Fazel S.
AIM: To establish and quantify the association between abuse-deterrent formulation (ADF) oxycodone and 1-year risk of opioid-related harm. DESIGN: Propensity score-matched cohort study of electronic medical records for years 2014 - 2018, with pat... (Source: SafetyLit)
Source: SafetyLit - January 6, 2021 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Sacklers Apologize but Deflect Blame at US  Congressional Opioid Hearing Sacklers Apologize but Deflect Blame at US  Congressional Opioid Hearing
Two members of the wealthy Sackler family who own OxyContin maker Purdue offered apologies on Thursday for the role the prescription painkiller has played in the deadly US opioid epidemic.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 18, 2020 Category: Consumer Health News Tags: Family Medicine/Primary Care News Source Type: news

Sacklers Face Furious Questions in Rare Testimony on Opioid Epidemic
It was the first time in years that members of the family that owns Purdue Pharma have taken questions publicly, but they continued to deny personal responsibility for the decades-long addiction crisis. (Source: NYT Health)
Source: NYT Health - December 18, 2020 Category: Consumer Health News Authors: Jan Hoffman Tags: Sackler Family Purdue Pharma Addiction (Psychology) Opioids and Opiates OxyContin (Drug) Pain-Relieving Drugs Sackler, David Sackler, Kathe Drug Abuse and Traffic House Committee on Oversight and Government Reform House of Representati Source Type: news

Sacklers Deny Personal Responsibility for Opioid Epidemic in House Hearing
It was the first time in years that members of the family that owns Purdue Pharma have taken questions publicly, and the exchanges were tense. (Source: NYT Health)
Source: NYT Health - December 18, 2020 Category: Consumer Health News Authors: Jan Hoffman Tags: United States Politics and Government Addiction (Psychology) Opioids and Opiates OxyContin (Drug) House of Representatives Purdue Pharma Sackler Family Sackler, David Sackler, Kathe Drug Abuse and Traffic your-feed-healthcare Source Type: news

Family behind OxyContin attests to its role in opioid crisis
Two members of the Sackler family that owns OxyContin maker Purdue Pharma have acknowledged the drug had a role in the opioid epidemic (Source: ABC News: Health)
Source: ABC News: Health - December 17, 2020 Category: Consumer Health News Tags: Health Source Type: news

Members of family that led maker of OxyContin deny responsibility for opioid crisis in congressional hearing
This was the first time in decades that members of the Sackler family that led OxyContin maker Purdue Pharma testified in public under oath. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - December 17, 2020 Category: Consumer Health News Authors: Meryl Kornfield Source Type: news

Senate Report: The Opioid Industry Has Paid Advocacy Groups $65 Million
A bipartisan congressional investigation released Wednesday found that key players in the nation’s opioid industry have spent $65 million since 1997 funding nonprofits that advocate treating pain with medications, a strategy intended to boost the sale of prescription painkillers. The report from Sens. Chuck Grassley of Iowa and Ron Wyden of Oregon found the contributions continued in recent years, even as the industry’s practices and the toll of opioid addiction came under greater scrutiny. The senators, the top Republican and Democrat on the Senate Finance Committee, are considering legislation to expand an ex...
Source: TIME: Health - December 17, 2020 Category: Consumer Health News Authors: GEOFF MULVIHILL / AP Tags: Uncategorized Drugs overnight wire Source Type: news

Little Change Seen in Rx of Opioids for Those at Risk for Misuse
After CDC guideline publication, there was a 14 percent decrease in oxycodone prescriptions, but not for other Schedule II opioids (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - December 16, 2020 Category: Psychiatry Tags: Family Medicine, Gynecology, Internal Medicine, Emergency Medicine, Orthopedics, Pharmacy, Psychiatry, Surgery, Anesthesiology & amp; Pain, Journal, Source Type: news

McKinsey issues a rare apology for its role in OxyContin sales
Facing mounting pressure about its role in the opioid crisis, McKinsey has taken the unusual step of acknowledging that its work with Purdue Pharma fell short of its standards and vowed a full internal review of its actions, including the possible destruction of documents. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 9, 2020 Category: Biotechnology Authors: Walt Bogdanich and Michael Forsythe Source Type: news